Glenmark Pharmaceuticals Ltd - The Bradford Era

Press Releases

Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg, 20 mg and 30 mg

Glenmark Pharmaceuticals Ltd

April 16, 2025

MAHWAH, N.J. , April 16, 2025 /PRNewswire/ --Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch [1] of Dextroamp...

Press Releases

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)

Glenmark Pharmaceuticals Ltd

March 20, 2025

MAHWAH, N.J. , March 20, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Dr...

Press Releases

Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)

Glenmark Pharmaceuticals Ltd

March 10, 2025

MAHWAH, N.J. , March 10, 2025 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch 1 of Polyethylene Glycol 33...

Press Releases

Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials

Glenmark Pharmaceuticals Ltd

March 3, 2025

MAHWAH, N.J. , March 3, 2025 /PRNewswire/ --Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch 1 of Acetylcysteine Inj...

Press Releases

Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial

Glenmark Pharmaceuticals Ltd

February 27, 2025

MAHWAH, N.J. , Feb. 27, 2025 /PRNewswire/ --Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch 1 of Epinephrine Injection USP, 10 mg/1...

Press Releases

Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)

Glenmark Pharmaceuticals Ltd

February 14, 2025

MAHWAH, N.J. , Feb. 14, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch 1 of Latanoprost Ophthalm...

Press Releases

Glenmark Pharmaceuticals Inc., USA launches Clindamycin Phosphate Foam, 1%

Glenmark Pharmaceuticals Ltd

February 13, 2025

MAHWAH, N.J. , Feb. 13, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch 1 of Clindamycin Phosphate Foam, 1%. G...

Press Releases

Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

Glenmark Pharmaceuticals Ltd

January 22, 2025

MAHWAH, N.J. , Jan. 22, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch 1 of Phytonadione Injectable Emulsion ...